SB3751Introduced in the Senate
Prescription Drug Supply Chain Pricing Transparency Act
Introduced by Michael Bennet, District CO
What does this bill do?
Plain-English breakdown
Checking for a plain-English summary…
Official description
A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Where it stands
Read twice and referred to the Committee on Finance.
January 29, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
Bill history
Read twice and referred to the Committee on Finance.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.